These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23793004)

  • 1. Numbers needed to treat (lives!) and numbers needed to save (money).
    Ribichini F; Taggart D; Vassanelli C
    EuroIntervention; 2013 Jun; 9(2):175-7. PubMed ID: 23793004
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness: the ménage à trois having a ratio with one denominator and one numerator.
    Serruys PW
    EuroIntervention; 2013 Jun; 9(2):173. PubMed ID: 23793003
    [No Abstract]   [Full Text] [Related]  

  • 3. Real value: a strategy for interventional cardiologists to lead healthcare reform.
    Duffy PL
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):188-91. PubMed ID: 24497462
    [No Abstract]   [Full Text] [Related]  

  • 4. The shifting price tag of pulmonary valve replacement.
    Kenny D; Hijazi ZM
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1154-5. PubMed ID: 24255032
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation: the European experience.
    Lange R; Bleiziffer S; Elhmidi Y; Piazza N
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S17-21. PubMed ID: 23410775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.
    Chevreul K; Brunn M; Cadier B; Haour G; Eltchaninoff H; Prat A; Leguerrier A; Blanchard D; Fournial G; Iung B; Donzeau-Gouge P; Tribouilloy C; Debrux JL; Pavie A; Gilard M; Gueret P;
    Arch Cardiovasc Dis; 2013 Apr; 106(4):209-19. PubMed ID: 23706367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hardest thing is to say no].
    Benamer H; Livarek B; Monségu J
    Ann Cardiol Angeiol (Paris); 2012 Dec; 61(6):403-4. PubMed ID: 23084364
    [No Abstract]   [Full Text] [Related]  

  • 9. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis.
    Clark MA; Arnold SV; Duhay FG; Thompson AK; Keyes MJ; Svensson LG; Bonow RO; Stockwell BT; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):697-704. PubMed ID: 22949492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the incremental cost of complications associated with mitral valve surgery in the United States.
    Iribarne A; Burgener JD; Hong K; Raman J; Akhter S; Easterwood R; Jeevanandam V; Russo MJ
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):864-72. PubMed ID: 22424521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
    Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of aortic valve replacement in elderly patients: an economic analysis.
    Wu Y; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):603-7. PubMed ID: 17320551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation should be controlled and monitored by the medical profession.
    Mayer JE
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):771-3. PubMed ID: 22424516
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of methodology and assumptions in a cost-effectiveness analysis on transcatheter aortic valve replacement.
    Osnabrugge RL; Kappetein AP
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):607. PubMed ID: 23321133
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost, effectiveness, and cost-effectiveness.
    Diamond GA; Kaul S
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):49-54. PubMed ID: 20031812
    [No Abstract]   [Full Text] [Related]  

  • 17. The limits of cost-effectiveness analysis.
    Weintraub WS; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):55-8. PubMed ID: 20031813
    [No Abstract]   [Full Text] [Related]  

  • 18. Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.
    Dahle G; Rein KA; Fiane A; Fosse E; Khushi I; Hagen T; Mishra V
    Scand Cardiovasc J; 2012 Dec; 46(6):345-52. PubMed ID: 22917262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new ESC/EACTS guidelines on the management of valvular heart disease.
    Vahanian A; Iung B
    Arch Cardiovasc Dis; 2012 Oct; 105(10):465-7. PubMed ID: 23062477
    [No Abstract]   [Full Text] [Related]  

  • 20. Do cardiology quality measures actually improve patient outcomes?
    Chatterjee P; Joynt KE
    J Am Heart Assoc; 2014 Feb; 3(1):e000404. PubMed ID: 24510114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.